Purdue Pharma has reached a tentative settlement agreement with several state attorneys general on its role in the US opioid crisis . The deal will remove Purdue from the first federal trial linked to the epidemic , scheduled for next month . Purdue must file for structured bankruptcy and , over time , pay $ 12bn , including around $ 3bn directly from the Sackler family . In addition , the company must surrender control of Purdue and sell Mundipharma for $ 1.5bn . Even with Wednesday’s development, many states have not signed on. While some lawyers said the deal was the " quickest and surest " way of securing compensation , others pledged to continue the legal battle .
Purdue Pharma has reached a tentative settlement agreement with several state attorneys general on its role in the US opioid crisis . The deal will remove Purdue from the first federal trial linked to the epidemic , scheduled for next month . Purdue must file for structured bankruptcy and , over time , pay $ 12bn , including around $ 3bn directly from the Sackler family . In addition , the company must surrender control of Purdue and sell Mundipharma for $ 1.5bn . While some lawyers said the deal was the " quickest and surest " way of securing compensation , others pledged to continue the legal battle .